23 August 2020 - Prostate cancer kills more than 3,000 men a year in Australia. But now many will have access to a lifesaving new treatment that can extend their life.
The $55,000-a-year treatment, called Nubeqa (darolutamide), has extended the life of men in a clinical trial by five years, but it was knocked back for a government subsidy on Friday.
Despite this, Bayer Australia has announced it will help nearly 2000 men with high-risk non-metastatic castration resistant prostate cancer, making Nubeqa available to at no cost.